These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4579978)

  • 1. The effect of antibacterial drugs on the ultrastructure of Mycobacterium leprae in human skin.
    Edwards RP; Draper GJ; Draper P
    Lepr Rev; 1972 Dec; 43(4):173-80. PubMed ID: 4579978
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro resistance test of human leprosy bacilli to anti-leprous drugs.
    Ishihara S; Hagiwara S; Fujuda T
    Microbios; 1977; 19(76):117-23. PubMed ID: 366337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of drugs against Mycobacterium leprae studied in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance in patients with leprosy in the United States.
    Williams DL; Lewis C; Sandoval FG; Robbins N; Keas S; Gillis TP; Scollard DM
    Clin Infect Dis; 2014 Jan; 58(1):72-3. PubMed ID: 24065328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrastructural alterations of mycobacterium leprae in skin biopsies of untreated and treated lepromatous patients.
    Silva MT; Macedo PM; Costa MH; Gonçalves H; Torgal J; David HL
    Ann Microbiol (Paris); 1982; 133(1):75-92. PubMed ID: 7051933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further experience with the rapid bactericidal effect of rifampin on Mycobacterium leprae.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1974 Nov; 23(6):1120-4. PubMed ID: 4611256
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid bactericidal effect of rifampin on Mycobacterium leprae.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1972 Jul; 21(4):446-9. PubMed ID: 4559066
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 15. An in vitro culture method for screening new drugs against Mycobacterium leprae.
    Dhople AM; Ortega I
    Indian J Lepr; 1990; 62(1):66-75. PubMed ID: 2193063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The killing of Mycobacterium leprae in mice by various dietary concentrations of dapsone and rifampicin.
    Gelber RH
    Lepr Rev; 1986 Dec; 57(4):347-53. PubMed ID: 3540497
    [No Abstract]   [Full Text] [Related]  

  • 19. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1968 Sep; 17(5):769-75. PubMed ID: 4877714
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of secondary dapsone resistance in Nepal.
    Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
    Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.